Avalon BioVentures I, LP

10% owner

Avalon BioVentures I, LP (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in JANX. The largest single filing was $14.2M of JANX (301,649 sh across 9 lots, as filed), executed Sep 26 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

–

no filings in the window

Last traded

Sep 27 2024

Filed Sep 30 2024

Open performance→

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 24 months

Most traded names

JANX JANX JANX · 0 buys · 1 sell 1 filing

Recent filings

JANXSALE Janux Therapeutics, Inc. View filing → $14.2M
301,649 sh across 9 lots
Exec Sep 26 2024
Filed Sep 30 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $21.2M
451,091 sh across 9 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $10.1M
240,000 sh across 3 lots
Exec Sep 6 2024
Filed Sep 10 2024 · 5:30 PM ET